Sumin Seo

Sumin Seo

Auto-generated profile, based on publicly available information

Sumin Seo

Korea Institute of Oriental Medicine, Daejeon, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2023 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
HJHyunchul Jang
Hyunchul Jang
SLSiwoo Lee
Siwoo Lee
YSYunhee Son
Yunhee Son
SSSumin Seo
Sumin Seo
YBYounghwa Baek
Younghwa Baek
JKJunho Kim
Junho Kim
Background: Patient-generated health data are important in the management of several diseases. Although there are limitations, information can be obtained using a wearable device and time-related information such as exercise time or sleep time can also be obtained. Fitbits can be used to acquire sleep onset, sleep offset, total sleep time (TST), and wakefulness after sleep onset (WASO) data, although there are limitations regarding the depth of sleep and satisfaction; therefore, the patient’s subjective response is still important information that cannot be replaced by wearable devices. Objective: To effectively use patient-generated health data related to time such as sleep, it is first necessary to understand the characteristics of the time response recorded by the user. Therefore, the aim of this study was to analyze the characteristics of individuals’ time perception in comparison with wearable data. Methods: Sleep data were acquired for 2 weeks using a Fitbit. Participants’ sleep records were collected daily through chatbot conversations while wearing the Fitbit, and the two sets of data were statistically compared. Results: In total, 736 people aged 30-59 years were recruited for this study, and the sleep data of 543 people who wore a Fitbit and responded to the chatbot for more than 7 days on the same day were analyzed. Research participants tended to respond to sleep-related times on the hour or in 30-minute increments, and each participant responded within the range of 60-90 minutes from the value measured by the Fitbit. On average for all participants, the chat responses and the Fitbit data were similar within a difference of approximately 15 minutes. Regarding sleep onset, the participant response was 8 minutes and 39 seconds (SD 58 minutes) later than that of the Fitbit data, whereas with respect to sleep offset, the response was 5 minutes and 38 seconds (SD 57 minutes) earlier. The participants’ actual sleep time (AST) indicated in the chat was similar to that obtained by subtracting the WASO from the TST measured by the Fitbit. The AST was 13 minutes and 39 seconds (SD 87 minutes) longer than the time WASO was subtracted from the Fitbit TST. On days when the participants reported good sleep, they responded 19 (SD 90) minutes longer on the AST than the Fitbit data. However, for each sleep event, the probability that the participant’s AST was within ±30 and ±60 minutes of the Fitbit TST-WASO was 50.7% and 74.3%, respectively. Conclusions: The chatbot sleep response and Fitbit measured time were similar on average and the study participants had a slight tendency to perceive a relatively long sleep time if the quality of sleep was self-reported as good. However, on a participant-by-participant basis, it was difficult to predict participants’ sleep duration responses with Fitbit data. Individual variations in sleep time perception significantly affect patient responses related to sleep, revealing the limitations of objective measures obtained through wearable devices.

24 August 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
AKAnna Kim
Anna Kim
YKYoung Eun Kim
Young Eun Kim
SSSumin Seo
Sumin Seo
SKSungha Kim
Sungha Kim
ECEunbyul Cho
Eunbyul Cho
MSMi Ju Son
Mi Ju Son
Introduction Herbal medicines (HMs) are commonly used during the postpartum period in South Korea. However, the safety concerns associated with these medicines remain unresolved. This study aims to establish a registry of patients receiving HM treatment during the postpartum period and collect clinical data on treatments and adverse reactions to build evidence evaluating the safety of HM use. Methods and analysis This study will use a prospective observational registry, including patients admitted to the obstetrics and gynaecology department of the Woosuk University Korean Medicine Hospital’s postpartum care centre. A total of 1000 eligible patients visiting the Korean medicine hospital to recover from various postchildbirth symptoms and opting for HM treatment will be enrolled in the registry. For safety assessment, demographic information, medical history, adverse events (AEs) and treatment details, including HM prescription and concomitant medication usage, will be collected throughout the patient’s hospitalisation period at the postpartum care centre for analysis. Adverse reactions will be monitored daily during hospitalisation, and collected AEs will be analysed for causality using the WHO Uppsala Monitoring Centre causality assessment and the Naranjo Algorithm Score. Ethics and dissemination This study was approved by the Institutional Review Board of Woosuk University Korean Medicine Medical Center (WSOH IRB H2311-03-01). The results will be published in peer-reviewed journals or disseminated through conference presentations. Trial registration number KCT0009060.

22 July 2025 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
BLBoram Lee
Boram Lee
GCGyu Tae Chang
Gyu Tae Chang
HLHyelim Lee
Hyelim Lee
Sun Haeng LeeSun Haeng Lee
Sun Haeng Lee
TKTae Hwan Kim
Tae Hwan Kim
MSMi Ju Son
Mi Ju Son
Allergic rhinitis is a prevalent immune disorder with a significant impact on quality of life and socioeconomic burden. Korean Medicine treatments such as herbal medicine and acupuncture are widely utilized for allergic rhinitis due to clinical effectiveness and patient preferences. In particular, herbal decoctions, a key component of Korean Medicine treatment for allergic rhinitis, offer personalized treatment but pose challenges for randomized controlled trials due to the difficulty of placebo development. This study aims to establish a registry utilizing real-world data (RWD) on Korean Medicine treatment for allergic rhinitis, focusing on the effectiveness, safety, and cost-effectiveness of herbal decoctions in clinical practice. The KOrean medicine REgistry for Allergic rhinitis in Real-world settings (KOREA-R) aims to enroll 400 patients with allergic rhinitis receiving Korean Medicine treatment at two Korean Medicine hospitals from February 2025 to June 2028. Patients will be examined in three visits at 2-week intervals, followed by two additional online follow-ups at 6 and 12 months after week 4. RWD on symptom severity, quality of life, treatment administration and compliance, adverse events, and laboratory blood tests will be collected. Participation is voluntary, with no restrictions on treatment types or dosages. Statistical analyses, including propensity score matching and difference-in-difference, will be used to evaluate the effectiveness, safety, and cost-effectiveness of Korean Medicine treatment, particularly herbal decoctions. Data management ensures confidentiality and quality through a validated electronic data capture system and regular monitoring. The findings of KOREA-R will provide insights into the effectiveness and safety of Korean Medicine treatment for allergic rhinitis, with a focus on herbal decoctions tailored to individual patient symptoms and pattern identifications. Additionally, by systematically collecting RWD for multidimensional analysis, KOREA-R will offer valuable information on the cost-utility and cost-effectiveness of herbal decoctions for both patients and healthcare policymakers. Clinical Research Information Service, KCT0010133 (Registration date: January 13, 2025).

24 May 2023 in JMIR Preprints
Verified
Preprint
Open access
HJHyunchul Jang
Hyunchul Jang
SLSiwoo Lee
Siwoo Lee
YSYunhee Son
Yunhee Son
SSSumin Seo
Sumin Seo
YBYounghwa Baek
Younghwa Baek
JKJunho Kim
Junho Kim
BACKGROUND Patient-generated health data are important in the management of several diseases. Although there are limitations, information can be obtained using a wearable device and time-related information such as exercise time or sleep time can also be obtained. Fitbits can be used to acquire sleep onset, sleep offset, total sleep time (TST), and wakefulness after sleep onset (WASO) data, although there are limitations regarding the depth of sleep and satisfaction; therefore, the patient’s subjective response is still important information that cannot be replaced by wearable devices. OBJECTIVE To effectively use patient-generated health data related to time such as sleep, it is first necessary to understand the characteristics of the time response recorded by the user. Therefore, the aim of this study was to analyze the characteristics of individuals’ time perception in comparison with wearable data. METHODS Sleep data were acquired for 2 weeks using a Fitbit. Participants’ sleep records were collected daily through chatbot conversations while wearing the Fitbit, and the two sets of data were statistically compared. RESULTS In total, 736 people aged 30-59 years were recruited for this study, and the sleep data of 543 people who wore a Fitbit and responded to the chatbot for more than 7 days on the same day were analyzed. Research participants tended to respond to sleep-related times on the hour or in 30-minute increments, and each participant responded within the range of 60-90 minutes from the value measured by the Fitbit. On average for all participants, the chat responses and the Fitbit data were similar within a difference of approximately 15 minutes. Regarding sleep onset, the participant response was 8 minutes and 39 seconds (SD 58 minutes) later than that of the Fitbit data, whereas with respect to sleep offset, the response was 5 minutes and 38 seconds (SD 57 minutes) earlier. The participants’ actual sleep time (AST) indicated in the chat was similar to that obtained by subtracting the WASO from the TST measured by the Fitbit. The AST was 13 minutes and 39 seconds (SD 87 minutes) longer than the time WASO was subtracted from the Fitbit TST. On days when the participants reported good sleep, they responded 19 (SD 90) minutes longer on the AST than the Fitbit data. However, for each sleep event, the probability that the participant’s AST was within ±30 and ±60 minutes of the Fitbit TST-WASO was 50.7% and 74.3%, respectively. CONCLUSIONS The chatbot sleep response and Fitbit measured time were similar on average and the study participants had a slight tendency to perceive a relatively long sleep time if the quality of sleep was self-reported as good. However, on a participant-by-participant basis, it was difficult to predict participants’ sleep duration responses with Fitbit data. Individual variations in sleep time perception significantly affect patient responses related to sleep, revealing the limitations of objective measures obtained through wearable devices.

17 April 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
AKAnna Kim
Anna Kim
ECEunbyul Cho
Eunbyul Cho
YKYoung-Eun Kim
Young-Eun Kim
SSSumin Seo
Sumin Seo
SKSungha Kim
Sungha Kim
MSMi Ju Son
Mi Ju Son
Background: Postpartum conditions significantly affect maternal and infant health. In South Korea, herbal medicine is commonly used for postpartum care in Korean medicine, but safety data remain limited. This study outlines a multicenter Korean medicine clinic registry designed to investigate treatment patterns and adverse events (AEs) associated with postpartum herbal medicine use. This primary care, practice-based research network registry will inform clinical decision-making and pharmacovigilance in postpartum care, supporting the quality and safety of care and guidance for comedication monitoring across community clinics. Objective: This study aims to establish a multicenter registry to investigate AEs and treatment patterns associated with postpartum herbal medicine use in Korean medicine clinics. Methods: This prospective observational registry will enroll postpartum patients receiving herbal medicine treatment from 15 Korean medicine clinics between July 2024 and June 2027, with a target sample size of 1000 participants. Patients within 6 months postpartum receiving herbal medicine will be included. Data will be collected for up to 8 weeks, including demographic information, medical history, herbal medicine prescriptions, AEs, and concomitant medication use. AEs are self-reported by patients, and causality is assessed using the World Health Organization Uppsala Monitoring Centre system and the Naranjo algorithm. Data collection and entry will follow standard operating procedures. Results: The registry was registered with the Clinical Research Information Service in June 2024 (KCT0009552). Recruitment began in July 2024 across 15 Korean medicine clinics and is planned to continue until June 2027 with a target enrollment of 1000 postpartum patients. Conclusions: This study represents the first large-scale, multicenter registry examining herbal medicine use during the postpartum period in Korean medicine clinics. By systematically collecting real-world data on AEs associated with postpartum herbal medicine use, we aim to establish a comprehensive safety database for individual herbal medicine and constituent herbs. The findings may support pharmacovigilance of herbal medicine and improve postpartum care outcomes for mothers and infants. Trial Registration: WHO ICTRP KCT0009552; https://trialsearch.who.int/?TrialID=KCT0009552 International Registered Report Identifier (IRRID): DERR1-10.2196/87543

9 December 2025 in Integrative Medicine Research
Verified
Journal Article
Open access
AKAnna Kim
Anna Kim
YKYoung Eun Kim
Young Eun Kim
SSSumin Seo
Sumin Seo
SKSungha Kim
Sungha Kim
ECEunbyul Cho
Eunbyul Cho
MSMi Ju Son
Mi Ju Son
Herbal medicines (HMs) are commonly used during the postpartum period in South Korea; however, comprehensive data regarding their safety remain limited. This study aimed to evaluate the safety of HM use among postpartum women through the “SAFEty of HErbal medicine REgistry in Postpartum Care center” (SAFEHERE-PC) study. A single-arm, prospective observational study was conducted from March to December 2024, enrolling 186 women within six weeks postpartum who were admitted to the postpartum care center of a Korean Medicine hospital. The study monitored adverse events (AEs) during HM use, collecting demographic information, medical history, herbal prescription details, and AE data. Reported AEs were analyzed using the WHO-UMC causality assessment and the Naranjo algorithm. Of the 186 participants, 4 (2.2 %) experienced AEs following HM administration, all of which were gastrointestinal symptoms (diarrhea, loose stools). Three of the five events were managed with a short course of the herbal formula, and two cases resolved spontaneously without requiring medical intervention. Based on severity and clinical course, the events were classified as mild to moderate. Causality assessment using the WHO-UMC system classified four cases as "possible" and one as "certain", while the Naranjo scale indicated three cases as "possible" and two as "probable" in their association with HM use. A low incidence of mild gastrointestinal AEs (2.2 % of patients; 0.6 % of prescriptions) was observed, with no serious AEs reported. These findings provide descriptive safety data specific to the formulations and clinical practices used at this hospital-based postpartum care center. Korean National Clinical Trial Registry Clinical Research Information Service: KCT0009060.